Global Molecular Diagnostics Market

The global Molecular Diagnostics Market was valued at USD 6.12 billion in 2016 and is projected to reach USD 12.93 billion by 2025, growing at a CAGR of 8.67% from 2017 to 2025.

Molecular diagnostics is a combination of techniques used to analyze biological markers in the genome and proteome, genetic code and cells expression in terms of gene as proteinsâ€"by applying molecular biology to medical testing.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increasing oncology studies and cancer patients
1.2 Growing demand of personalized medicines
1.3 Growing Market of molecular biology and biomarker techniques in healthcare
1.4 Assured reimbursements

2. Market Restraints
2.1 Stringent regulations

Market Segmentation:
1. Global Molecular Diagnostics Market, by Technology:
1.1 Polymerase Chain Reaction (PCR)
1.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
1.3 Hybridization (In-Situ Hybridization & Fish)
1.4 DNA Sequencing and Next-Generation Sequencing
1.5 Microarray
1.6 Other Technologies

2. Global Molecular Diagnostics Market, by Application:
2.1 Infectious Diseases
2.1.1 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
2.1.2 Hepatitis B
2.1.3 Human Papillomavirus (HPV)
2.1.4 Human Immunodeficiency Virus (HIV)
2.1.5 Tuberculosis (TB)
2.1.6 Hepatitis C
2.1.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
2.1.8 Other Infectious Diseases
2.2 Oncology
2.2.1 Breast Cancer
2.2.2 Colorectal Cancer
2.2.3 Prostate Cancer
2.2.4 Other Cancers
2.3 Blood Screening
2.4 Genetic Tests
2.5 Microbiology
2.6 Other Applications

3. Global Molecular Diagnostics Market, by End User:
3.1 Hospital and Academic Laboratories
3.2 Reference Laboratories
3.3 Other End Users

4. Global Molecular Diagnostics Market, by Products and Services:
4.1 Reagents & Kits
4.2 Instruments
4.3 Software & Services

5. Global Molecular Diagnostics Market, by Region:
5.1 North America (U.S., Canada, Mexico)
5.2 Europe (Germany, UK, France, Rest of Europe)
5.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
5.4 Latin America (Brazil, Argentina, Rest of Latin America)
5.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Abbott Laboratories
2. Qiagen N.V.
3. Roche Diagnostics
4. Hologic, Inc.
5. Grifols
6. Siemens Healthcare
7. Becton, Dickinson and Company
8. Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
9. Biomérieux Sa
10. Cepheid Inc.

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Molecular Diagnostics Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.